BaFin Error at Mutares 2023: Receivables from Related Companies

The legal basis for BaFin's jurisdiction is Section 16 (1) of the Securities Trading Act (Wertpapierhandelsgesetz, WpHG). Since January 1, 2022, BaFin has been solely responsible for the balance sheet control of capital market-oriented companies. In doing so, the authority reviews the legality of annual and consolidated financial statements as well as the associated management reports. If it identifies errors, it publishes them – with the aim of informing the capital market about material balance sheet violations and strengthening investor confidence.

Mutares' Response

Mutares stated that the corresponding disclosure had already been added in the published 2024 and 2025 annual financial statements, "including a retrospective presentation as of December 31, 2023." The company also emphasized that "with this, Mutares has already fully taken into account the interest in information regarding the residual maturity of receivables from related companies prior to the completion of the review by BaFin." According to Mutares, BaFin's review of the disclosures on expected development in the combined management and group management report was completed without objections.

Background: Delayed Financial Statements and SDAX Exclusion

BaFin had initiated the review of Mutares' annual financial statements and management report almost a year ago because it saw concrete indications that Mutares may have violated accounting regulations. As early as spring 2025, the company had caused unrest among investors with balance sheet problems: At that time, Mutares had to postpone the presentation of the audited consolidated and annual financial statements for 2024. The auditing firm Deloitte justified this at the time with "complex special circumstances" that had prevented on-schedule completion.

Price Reaction and Analyst Opinions

Due to the delayed presentation of financial statements, Mutares was temporarily removed from the small-cap index SDAX; the annual general meeting also had to be postponed. After the BaFin proceedings became known, the Mutares share temporarily dropped by more than a fifth. On a twelve-month view, the stock continues to post losses of around 22 percent; in the current year, it is slightly in negative territory. At the start of trading on Tuesday, the stock listed on the SDAX initially gained nearly four percent but gave back much of those gains. Most recently, the stock was barely one percent in positive territory.

Despite the ongoing balance sheet issues, analysts remain confident. Warburg Research issued a "Buy" rating on Mutares on December 10, 2025. On March 16, 2026, Jefferies & Company Inc. also confirmed a buy recommendation. According to information from Mutares' circle, the affected related companies are investments in other firms, specifically private equity investments.

With the conclusion of the BaFin proceedings, the review of Mutares' 2023 annual financial statements is ended. For investors, this means that the material balance sheet allegation has now been transparently addressed – albeit against the backdrop of a longer-standing climate of strained trust toward the company.